Scholarly Index
Peter M. Irving
Guy's and St Thomas' NHS Foundation Trust; 17,236 total citations; 611 total publications; best world rank #26
Guy's and St Thomas' NHS Foundation Trust
17,236Total citations
611Total publications
71H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Inflammatory Bowel Disease | Lifetime | 100 | GB 8 | 99.35 |
| Microscopic Colitis | Lifetime | 144 | GB 10 | 99.06 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 854 | GB 77 | 96.79 |
| Biosimilars and Bioanalytical Methods | Lifetime | 291 | GB 22 | 95.18 |
| Eosinophilic Esophagitis | Lifetime | 732 | GB 56 | 96.66 |
| Autoimmune and Inflammatory Disorders | Lifetime | 251 | GB 24 | 96.34 |
| Gastrointestinal motility and disorders | Lifetime | 713 | GB 66 | 95.53 |
| Diagnosis and treatment of tuberculosis | Lifetime | 928 | GB 94 | 90.51 |
| Inflammatory Bowel Disease | 2021-2025 | 26 | GB 1 | 99.67 |
| Microscopic Colitis | 2021-2025 | 52 | GB 4 | 99.22 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 55 | GB 4 | 98.15 |
| Eosinophilic Esophagitis | 2021-2025 | 113 | GB 8 | 97.25 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 130 | GB 9 | 93.07 |
| Diverticular Disease and Complications | 2021-2025 | 171 | GB 11 | 90.36 |
| Pharmaceutical studies and practices | 2021-2025 | 464 | GB 28 | 83.08 |
| Anorectal Disease Treatments and Outcomes | 2021-2025 | 495 | GB 36 | 82.77 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 235 | GB 3 | 83.22 |